US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aptevo Therapeutics

1.38

+0.381938.26%

Post-market: 2.370.9900+71.74%19:59 EDT

Volume:27.46M

Turnover:67.24M

Market Cap:2.01M

PE:-0.02

High:3.61

Open:0.9950

Low:0.9950

Close:0.9981

Loading ...

Overview Company News Filings

Aptevo Therapeutics trading halted, news pending

Top Midday Decliners

MT Newswires Live

Aptevo Therapeutics Announces 1-for-37 Reverse Stock Split

MT Newswires Live

BRIEF-Aptevo Therapeutics Announces 1-For 37 Reverse Stock Split As Part Of Nasdaq Compliance Plan

Aptevo Therapeutics announces 1-for-37 reverse stock split

Aptevo Therapeutics Inc - Announces 1-for 37 Reverse Stock Split as Part of Nasdaq Compliance Plan

THOMSON REUTERS

Aptevo Therapeutics Announces 1-for 37 Reverse Stock Split As Part of Nasdaq Compliance Plan

Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation

Aptevo Therapeutics highlights potential of portfolio in cancer immunotherapy

Aptevo Highlights the Potential of the Company's Robust Portfolio in Cancer Immunotherapy, the Success of Bispecifics as a Category, and Their Growing Importance in the Oncology Treatment Paradigm

Sector Update: Health Care Stocks Advance Wednesday Afternoon

MT Newswires Live

Aptevo Therapeutics Shares Gain After First Dosed Patient in AML Trial Shows 90% Reduction in Leukemic Blasts

MT Newswires Live

BRIEF-First Patient Dosed In Ongoing Rainier Trial Achieved 90% Reduction In Leukemic Blasts Within The First 30 Days Of Treatment

Aptevo Therapeutics - Favorable Early Safety, Efficacy, Tolerability,Durability of Remission Data Informed Co's Ongoing Rainier Phase 1B/2 Trial

THOMSON REUTERS

Aptevo Therapeutics - First Patient Dosed in Ongoing Rainier Trial Achieved 90% Reduction in Leukemic Blasts Within the First 30 Days of Treatment

THOMSON REUTERS

First Patient Dosed in Aptevo's Ongoing RAINIER Trial Achieves 90% Reduction in Leukemic Blasts Within the First 30 Days of Treatment, Continues Overall Efficacy Trend Seen in Prior Mipletamig AML Studies

Aptevo Therapeutics' Bispecific Antibody Meets Trial Endpoints

MT Newswires Live

Aptevo announces ALG.APV-527 meets trial endpoints in Phase 1 study

First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial

Aptevo Therapeutics Q3 2024 GAAP EPS $(0.48) Beats $(3.35) Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/APVO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APVO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APVO\",,,,,undefined,":{"symbol":"APVO","market":"US","secType":"STK","nameCN":"Aptevo Therapeutics","latestPrice":1.38,"timestamp":1743624000000,"preClose":0.9981,"halted":0,"volume":27461744,"hourTrading":{"tag":"盘后","latestPrice":2.37,"preClose":1.38,"latestTime":"19:59 EDT","volume":5674684,"amount":13006745.1515,"timestamp":1743638398755},"delay":0,"floatShares":1458281,"shares":1458445,"eps":-87.38416,"marketStatus":"Not Yet Opened","change":0.3819,"latestTime":"04-02 16:00:00 EDT","open":0.995,"high":3.61,"low":0.995,"amount":67237243.3858448,"amplitude":2.619978,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-87.38416,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743667200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.9981,"preHourTrading":{"tag":"盘前","latestPrice":0.9601,"preClose":0.9981,"latestTime":"09:16 EDT","volume":1447,"amount":1392.5282637999999,"timestamp":1743599790650},"postHourTrading":{"tag":"盘后","latestPrice":2.37,"preClose":1.38,"latestTime":"19:59 EDT","volume":5674684,"amount":13006745.1515,"timestamp":1743638398755},"volumeRatio":175.672413},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APVO\",,,,,undefined,":{"symbol":"APVO","floatShares":1458281,"roa":"-76.06%","roe":"-284.28%","lyrEps":-87.38416,"volumeRatio":175.672413,"shares":1458445,"dividePrice":0,"high":3.61,"amplitude":2.619978,"preClose":0.9981,"low":0.995,"week52Low":0.9423,"pbRate":"0.42","week52High":180.19,"institutionHeld":0,"latestPrice":1.38,"eps":-87.38416,"divideRate":0,"volume":27461744,"delay":0,"ttmEps":-87.38416,"open":0.995,"prevYearClose":4.31,"prevWeekClose":1.12,"prevMonthClose":1.16,"prevQuarterClose":1.16,"fiveDayClose":1.54,"twentyDayClose":2.77,"sixtyDayClose":4.58},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APVO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2488042649","title":"Aptevo Therapeutics trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2488042649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488042649?lang=en_us&edition=fundamental","pubTime":"2024-12-04 08:55","pubTimestamp":1733273759,"startTime":"0","endTime":"0","summary":"19:50 EST Aptevo Therapeutics (APVO) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aptevo-therapeutics-trading-halted-news-pending-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aptevo-therapeutics-trading-halted-news-pending-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APVO","BK4139"],"gpt_icon":0},{"id":"2487598353","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2487598353","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487598353?lang=en_us&edition=fundamental","pubTime":"2024-11-30 01:58","pubTimestamp":1732903130,"startTime":"0","endTime":"0","summary":"Applied Therapeutics (APLT) late Wednesday said the US Food and Drug Administration has issued a complete response letter indicating its decision to not approve a new drug application for the company'","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","RMBL","APLT","APVO","BK4122","LU0109394709.USD","LU0320765992.SGD","BK4214","BK4139"],"gpt_icon":0},{"id":"2487566313","title":"Aptevo Therapeutics Announces 1-for-37 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2487566313","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487566313?lang=en_us&edition=fundamental","pubTime":"2024-11-29 23:38","pubTimestamp":1732894727,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics  said Friday it will conduct a 1-for-37 reverse stock split, effective Tuesday, to help the company meet Nasdaq's minimum bid price requirement of $1 per share.The split-adjusted shares will begin trading on the Nasdaq Capital Market on Wednesday, the company said.The reverse stock split will reduce Aptevo's outstanding number of shares to about 500,000 from 18.5 million and adjust outstanding options, warrants, and other securities, the company added.Aptevo shares dropped about 18% in recent trading.Price: 0.28, Change: -0.06, Percent Change: -17.67","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NQmain","BK4139","APVO"],"gpt_icon":0},{"id":"2487896563","title":"BRIEF-Aptevo Therapeutics Announces 1-For 37 Reverse Stock Split As Part Of Nasdaq Compliance Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2487896563","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487896563?lang=en_us&edition=fundamental","pubTime":"2024-11-29 23:07","pubTimestamp":1732892824,"startTime":"0","endTime":"0","summary":"BRIEF-Aptevo Therapeutics Announces 1-For 37 Reverse Stock Split As Part Of Nasdaq Compliance PlanNov 29  - Aptevo Therapeutics Inc APVO.O:APTEVO THERAPEUTICS INC - ANNOUNCES 1-FOR 37 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLANAPTEVO THERAPEUTICS INC -REVERSE STOCK SPLIT IS EXPECTED TO BECOME EFFECTIVE ON DEC 3Source text: [ID:]Further company coverage: APVO.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241129:nFWN3N00I5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APVO"],"gpt_icon":0},{"id":"2487563064","title":"Aptevo Therapeutics announces 1-for-37 reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2487563064","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487563064?lang=en_us&edition=fundamental","pubTime":"2024-11-29 23:00","pubTimestamp":1732892418,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics (APVO) announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-37. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aptevo-therapeutics-announces-1-for-37-reverse-stock-split?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aptevo-therapeutics-announces-1-for-37-reverse-stock-split?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APVO","BK4139"],"gpt_icon":0},{"id":"2487681345","title":"Aptevo Therapeutics Inc - Announces 1-for 37 Reverse Stock Split as Part of Nasdaq Compliance Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2487681345","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487681345?lang=en_us&edition=fundamental","pubTime":"2024-11-29 22:56","pubTimestamp":1732892211,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241129:nFWN3N00I5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APVO","BK4139"],"gpt_icon":0},{"id":"2487565850","title":"Aptevo Therapeutics Announces 1-for 37 Reverse Stock Split As Part of Nasdaq Compliance Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2487565850","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487565850?lang=en_us&edition=fundamental","pubTime":"2024-11-29 22:55","pubTimestamp":1732892100,"startTime":"0","endTime":"0","summary":"SEATTLE, WA / ACCESSWIRE / November 29, 2024 / Aptevo Therapeutics Inc.  , today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-37 . The Reverse Stock Split is expected to become effective on December [3], 2024 at 5:01 p.m. Eastern Time , with shares expected to begin trading on the Nasdaq Capital Market, on a split-adjusted, at market open on December [4], 2024. In connection with the Reverse Stock Split, every 37 shares of the Company's common stock issued and outstanding as of the Effective Time will be automatically converted into one share of the Company's common stock. No change will be made to the trading symbol for the Company's shares of common stock, \"APVO\", in connection with the reverse split.Additional information regarding the reverse stock split is available in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission  on October 3, 2024 and a Current Report on Form ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aptevo-therapeutics-announces-1-37-145500304.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MNQmain","SQQQ","QLD","TQQQ","QID","IE00BGHQF748.EUR","BK4585","BK4139","NDAQ","LU2210150020.SGD","NQmain","BK4588",".IXIC","LU2095319765.USD","LU2210149790.SGD","APVO","BK4112","IE00B3QW5Z07.USD","IE00BKPKM429.USD","PSQ","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2486008046","title":"Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2486008046","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486008046?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:35","pubTimestamp":1732628100,"startTime":"0","endTime":"0","summary":"Aptevo's Peter Pavlik, PhD, to chair a session on \"Bi and Multispecific Biologics\" and will also give talk titled \"Modular Multispecific Biotherapeutics: Rapid Therapeutic Design with the ADAPTIR Platform\" at Cambridge Healthcare Institute's, Pep Talk 2025. \"Therapeutic candidates are often talked about once they are in human trials, especially when positive results are generated. But the genesis of those drugs and the speed with which they are produced, serves as the backbone of all therapeutic innovation. We work to create molecules that will be safe and tolerable in humans and target cancers as directly and effectively as possible,\" said Dr. Pavlik. \"My presentation will describe how employing modular biotherapeutics can drive pipeline productivity, a critical capability, especially for smaller biotechnology companies navigating a competitive landscape. More specifically, we will explore the power of Aptevo's ADAPTIR and ADAPTIR-FLEX platform technologies, which enable the rapid dev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/proving-concept-aptevo-technology-pipeline-133500344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4084","APVO","PW","BK4234"],"gpt_icon":0},{"id":"2485263507","title":"Aptevo Therapeutics highlights potential of portfolio in cancer immunotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2485263507","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485263507?lang=en_us&edition=fundamental","pubTime":"2024-11-22 21:40","pubTimestamp":1732282808,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics (APVO) provided additional details about its oncology pipeline which is poised to potentially address some of the most challeng...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aptevo-therapeutics-highlights-potential-of-portfolio-in-cancer-immunotherapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aptevo-therapeutics-highlights-potential-of-portfolio-in-cancer-immunotherapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APVO","BK4139"],"gpt_icon":0},{"id":"2485263669","title":"Aptevo Highlights the Potential of the Company's Robust Portfolio in Cancer Immunotherapy, the Success of Bispecifics as a Category, and Their Growing Importance in the Oncology Treatment Paradigm","url":"https://stock-news.laohu8.com/highlight/detail?id=2485263669","media":"ACCESSWIRE","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485263669?lang=en_us&edition=fundamental","pubTime":"2024-11-22 21:35","pubTimestamp":1732282500,"startTime":"0","endTime":"0","summary":"Developing innovative bispecific antibodies for monotherapy and combination with the potential to expand the frontiers of cancer treatment. SEATTLE, WA / ACCESSWIRE / November 22, 2024 / Aptevo Therapeutics , a leader in the development of novel bispecific antibodies for cancer treatment, provided additional details about its robust oncology pipeline which is poised to potentially address some of the most challenging and aggressive forms of cancer in both blood and solid tumors. As bispecific antibodies gain prominence for their revolutionary therapeutic potential and expanding market opportunities, Aptevo's differentiated platforms  and promising clinical results across two clinical programs , together with preclinical assets  are demonstrating how bispecifics rationally differentiated for safety and targeted efficacy may impact the future of cancer care. The company plans to add another targeted asset to the pipeline in the near-term and looks forward to providing more detail about t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aptevo-highlights-potential-companys-robust-133500685.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SD","BK4139","BK4213","APVO"],"gpt_icon":0},{"id":"2485294961","title":"Sector Update: Health Care Stocks Advance Wednesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2485294961","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485294961?lang=en_us&edition=fundamental","pubTime":"2024-11-21 03:00","pubTimestamp":1732129225,"startTime":"0","endTime":"0","summary":"Health care stocks were higher Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each up about 0.8%.The iShares Biotechnology ETF (IBB) added 0.6%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0466842654.USD","LU0070302665.USD","SG9999002224.SGD","EYEN","BK4588","LU1585245621.USD","BK4568","LU2468319806.SGD","JNJ","LU1989772840.SGD","APVO","LU0965508806.USD","LU0965509101.SGD","IE00BLSP4452.SGD","LU0265550946.USD","LU0882574055.USD","IBB","XLV","LU0795875169.SGD","LU0122379950.USD","LU1291159041.SGD","LU2361045086.USD","BK4534","IE0009355771.USD","LU1244550577.SGD","LU1261432733.SGD","LU1732799900.SGD","BK4504","LU1989771016.USD","LU1674673428.USD","BK4532","LU1941712264.USD","BK4007","LU1934455277.USD","LU1074936037.SGD","LU1196500208.SGD","LU0266013472.USD","LU2461242641.AUD","MRK","LU1093756325.SGD","IE00B4R5TH58.HKD","LU0345770308.USD","IE00B1BXHZ80.USD","LU0058720904.USD","LU0320765646.SGD","SG9999001440.SGD","BK4585","LU1032955483.USD","LU1116320901.HKD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2484112049","title":"Aptevo Therapeutics Shares Gain After First Dosed Patient in AML Trial Shows 90% Reduction in Leukemic Blasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2484112049","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484112049?lang=en_us&edition=fundamental","pubTime":"2024-11-20 22:32","pubTimestamp":1732113162,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics  was advancing almost 7% Wednesday after the company said the first patient with acute myeloid leukemia dosed in a phase 1b/2 trial evaluating its mipletamig immune-oncology candidate together with standard of care venetoclax and azacitidine achieved a 90% reduction in leukemic blasts within the first 30 days of treatment.The encouraging initial results continue the overall efficacy, safety and tolerability seen for mipletamig in prior studies, alongside evidence of durable remission, the biotechnology company said.The open-label study is evaluating the combination of mipletamig with standard of care treatments as frontline combination therapy for leukemia in as many of 39 patients who will be treated across five dosing levels.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APVO","BK4139"],"gpt_icon":0},{"id":"2484439119","title":"BRIEF-First Patient Dosed In Ongoing Rainier Trial Achieved 90% Reduction In Leukemic Blasts Within The First 30 Days Of Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2484439119","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484439119?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:43","pubTimestamp":1732110198,"startTime":"0","endTime":"0","summary":"Nov 20  - Aptevo Therapeutics Inc   :   * APTEVO THERAPEUTICS - FIRST PATIENT DOSED IN ONGOING RAINIER TRIAL ACHIEVED 90% REDUCTION IN LEUKEMIC BLASTS WITHIN THE FIRST 30 DAYS OF TREATMENT   * APTEVO THERAPEUTICS - FAVORABLE EARLY SAFETY, EFFICACY, TOLERABILITY,DURABILITY OF REMISSION DATA INFORMED CO'S ONGOING RAINIER PHASE 1B/2 TRIALSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APVO"],"gpt_icon":0},{"id":"2484511911","title":"Aptevo Therapeutics - Favorable Early Safety, Efficacy, Tolerability,Durability of Remission Data Informed Co's Ongoing Rainier Phase 1B/2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2484511911","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484511911?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:39","pubTimestamp":1732109970,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nFWN3MR0N2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APVO","BK4139"],"gpt_icon":0},{"id":"2484195119","title":"Aptevo Therapeutics - First Patient Dosed in Ongoing Rainier Trial Achieved 90% Reduction in Leukemic Blasts Within the First 30 Days of Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2484195119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484195119?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:39","pubTimestamp":1732109970,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nFWN3MR0N2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APVO"],"gpt_icon":0},{"id":"2484112651","title":"First Patient Dosed in Aptevo's Ongoing RAINIER Trial Achieves 90% Reduction in Leukemic Blasts Within the First 30 Days of Treatment, Continues Overall Efficacy Trend Seen in Prior Mipletamig AML Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2484112651","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484112651?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:35","pubTimestamp":1732109700,"startTime":"0","endTime":"0","summary":"Potential to redefine frontline AML treatment being evaluated in clinic: Mipletamig, CD3 x CD123 bispecific, in combination with standard of care, offers a multi-mechanism strategy for potential improved patient outcomes. Favorable early safety, efficacy, tolerability and durability of remission data informed Aptevo's ongoing RAINIER Phase 1b/2 trial. Dr. Huebner continued, \"To date, mipletamig has demonstrated a strong safety profile with manageable incidence and severity of the most common therapeutic side effect, cytokine release syndrome , below levels seen with other treatment modalities of similar therapeutic mechanisms of action. Strong support for the development of a triplet combination that includes mipletamig is driven by efficacy data from prior mi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/first-patient-dosed-aptevos-ongoing-133500725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B66KJ199.SGD","BK4139","BK4006","IE00B7SZL793.SGD","IE00B19Z4B17.USD","APVO","CRS","IE0031619046.USD"],"gpt_icon":0},{"id":"2482315780","title":"Aptevo Therapeutics' Bispecific Antibody Meets Trial Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2482315780","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482315780?lang=en_us&edition=fundamental","pubTime":"2024-11-11 22:27","pubTimestamp":1731335272,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics  said Monday that a phase 1 trial of ALG.APV-527 to treat solid tumors has met the trial endpoint of adequate exposure, safety, tolerability and biological activity.\"The interim results from phase 1 trials of ALG.APV-527 are showing encouraging outcomes, particularly in terms of safety and disease stability in the trial patients who were refractory to multiple previous therapies,\" Thomas Marron, the trial's lead investigator, said in a statement.Price: 0.2648, Change: +0.01, Percent Change: +2.64","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APVO","BK4139"],"gpt_icon":0},{"id":"2482704784","title":"Aptevo announces ALG.APV-527 meets trial endpoints in Phase 1 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2482704784","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482704784?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:45","pubTimestamp":1731332737,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics (APVO) and Alligator Bioscience announced preliminary data from the companies’ Phase 1 trial evaluating the first-in-class bisp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aptevo-announces-alg-apv-527-meets-trial-endpoints-in-phase-1-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aptevo-announces-alg-apv-527-meets-trial-endpoints-in-phase-1-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APVO","BK4139"],"gpt_icon":0},{"id":"2482845157","title":"First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2482845157","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482845157?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:05","pubTimestamp":1731330300,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable disease. Colon cancer patient achieved stable disease and remained on study for more than six months, breast cancer patient remained on study for more than 11 months. Biomarker analysis confirms immune activation in the tumor microenvironment. SEATTLE, WA and LUND, SWEDEN / ACCESSWIRE / November 11, 2024 / Aptevo Therapeutics   and Alligator Bioscience AB   today announced preliminary data from the companies' Phase 1 trial evaluating the first-in-class bispecific antibody, ALG.APV-527, as monotherapy for the treatment of multiple solid tumor types likely to express tumor antigen 5T4. These data indicate that trial endpoints of adequate exposure, safety, tolerability and biological activity were met. Outcomes were presented at a poster session on Friday November 8, 2024, at the Society for Immunotherap","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/first-class-bispecific-antibody-alg-130500184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4213","SD","APVO"],"gpt_icon":0},{"id":"2481907879","title":"Aptevo Therapeutics Q3 2024 GAAP EPS $(0.48) Beats $(3.35) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481907879","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481907879?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:28","pubTimestamp":1730986127,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(3.35) by 85.67 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41806248/aptevo-therapeutics-q3-2024-gaap-eps-0-48-beats-3-35-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Aptevo Therapeutics Q3 2024 GAAP EPS $(0.48) Beats $(3.35) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APVO"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":46}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APVO\",params:#limit:5,,,undefined,":[{"date":"2025-02-14","symbol":"APVO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739523600000,"name":null,"time":"Pre-Market","dateTimestamp":1739509200000,"actualEps":null},{"market":"US","date":"2024-12-04","symbol":"APVO","defaultRemindTime":1733322600000,"type":"split","dateTimestamp":1733288400000,"forFactor":37,"toFactor":1,"ratio":37},{"market":"US","date":"2024-11-07","symbol":"APVO","fiscalQuarterEnding":"2024/09","expectedEps":-0.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2024-08-08","symbol":"APVO","fiscalQuarterEnding":"2024/06","expectedEps":-1.93,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-1.67},{"market":"US","date":"2024-05-08","symbol":"APVO","fiscalQuarterEnding":"2024/03","expectedEps":-14.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-9.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APVO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APVO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1696910400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APVO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APVO","date":"2025-04-01","current":-0.070112,"percent":0.771104,"low":-10.622263,"twenty":-2.459807,"median":-0.255408,"eighty":0.262505,"high":3.317157,"avg":-1.129663,"sd":2.733638,"marketCap":1691796},"quantilePoints":[{"date":"2020-04-03","current":-0.248676,"twenty":-0.788054,"median":-0.655053,"eighty":14.257552,"marketCap":10058449},{"date":"2020-04-09","current":-0.30704,"twenty":-0.788054,"median":-0.653053,"eighty":14.231805,"marketCap":12419155},{"date":"2020-04-17","current":-0.316635,"twenty":-0.78788,"median":-0.651279,"eighty":14.122379,"marketCap":12807253},{"date":"2020-04-24","current":-0.342222,"twenty":-0.787635,"median":-0.647941,"eighty":14.045137,"marketCap":13842183},{"date":"2020-05-01","current":-0.419781,"twenty":-0.786474,"median":-0.647742,"eighty":14.006516,"marketCap":16979313},{"date":"2020-05-08","current":-0.502938,"twenty":-0.786196,"median":-0.647364,"eighty":13.974332,"marketCap":20342834},{"date":"2020-05-15","current":-0.692573,"twenty":-0.786196,"median":-0.647396,"eighty":13.813411,"marketCap":17683476},{"date":"2020-05-22","current":-0.822985,"twenty":-0.786196,"median":-0.64765,"eighty":13.77479,"marketCap":21013271},{"date":"2020-05-29","current":-0.721694,"twenty":-0.786196,"median":-0.647941,"eighty":13.658928,"marketCap":18427022},{"date":"2020-06-05","current":-0.730557,"twenty":-0.785096,"median":-0.650558,"eighty":13.562376,"marketCap":18653319},{"date":"2020-06-12","current":-0.681178,"twenty":-0.786196,"median":-0.652052,"eighty":13.530192,"marketCap":17392523},{"date":"2020-06-19","current":-0.769807,"twenty":-0.785096,"median":-0.654643,"eighty":13.509222,"marketCap":19655490},{"date":"2020-06-26","current":-1.038227,"twenty":-0.786196,"median":-0.655934,"eighty":13.503825,"marketCap":26509050},{"date":"2020-07-02","current":-1.162308,"twenty":-0.787967,"median":-0.656676,"eighty":13.496349,"marketCap":29677204},{"date":"2020-07-10","current":-0.973654,"twenty":-0.788324,"median":-0.658898,"eighty":13.395018,"marketCap":24860316},{"date":"2020-07-17","current":-0.992646,"twenty":-0.791378,"median":-0.65946,"eighty":13.175771,"marketCap":25345238},{"date":"2020-07-24","current":-1.020501,"twenty":-0.793706,"median":-0.660268,"eighty":13.03755,"marketCap":26056456},{"date":"2020-07-31","current":-1.06355,"twenty":-0.797409,"median":-0.661301,"eighty":12.777162,"marketCap":27155612},{"date":"2020-08-07","current":-1.06988,"twenty":-0.801094,"median":-0.661477,"eighty":12.038388,"marketCap":27317252},{"date":"2020-08-14","current":-1.355794,"twenty":-0.804169,"median":-0.662186,"eighty":11.463113,"marketCap":25765503},{"date":"2020-08-21","current":-1.495286,"twenty":-0.808908,"median":-0.663688,"eighty":11.021059,"marketCap":28416408},{"date":"2020-08-28","current":-1.372805,"twenty":-0.81215,"median":-0.663922,"eighty":10.324675,"marketCap":26088784},{"date":"2020-09-04","current":-1.337081,"twenty":-0.816597,"median":-0.664991,"eighty":10.209623,"marketCap":25409894},{"date":"2020-09-11","current":-1.279243,"twenty":-0.818533,"median":-0.665547,"eighty":10.136956,"marketCap":24310738},{"date":"2020-09-18","current":-1.326875,"twenty":-0.826968,"median":-0.66627,"eighty":9.979509,"marketCap":25215925},{"date":"2020-09-25","current":-1.240117,"twenty":-0.835327,"median":-0.667339,"eighty":9.894732,"marketCap":23567192},{"date":"2020-10-02","current":-1.306461,"twenty":-0.839016,"median":-0.668655,"eighty":9.737292,"marketCap":24827988},{"date":"2020-10-09","current":-1.219704,"twenty":-0.845781,"median":-0.671339,"eighty":9.67068,"marketCap":23179254},{"date":"2020-10-16","current":-1.187383,"twenty":-0.850697,"median":-0.673566,"eighty":9.537456,"marketCap":22565020},{"date":"2020-10-23","current":-1.192486,"twenty":-0.855424,"median":-0.675811,"eighty":9.283127,"marketCap":22662005},{"date":"2020-10-30","current":-1.098924,"twenty":-0.864478,"median":-0.677891,"eighty":9.222572,"marketCap":20883959},{"date":"2020-11-06","current":-4.031658,"twenty":-0.87135,"median":-0.678444,"eighty":9.174128,"marketCap":76617620},{"date":"2020-11-13","current":-9.879847,"twenty":-0.88165,"median":-0.679314,"eighty":9.14385,"marketCap":186442594},{"date":"2020-11-20","current":-10.022619,"twenty":-0.893651,"median":-0.681918,"eighty":9.010628,"marketCap":189136851},{"date":"2020-11-27","current":-9.750254,"twenty":-0.903209,"median":-0.68286,"eighty":8.962184,"marketCap":183997038},{"date":"2020-12-04","current":-10.040191,"twenty":-0.911128,"median":-0.684423,"eighty":8.841074,"marketCap":189468452},{"date":"2020-12-11","current":-9.673376,"twenty":-0.915089,"median":-0.685404,"eighty":8.659408,"marketCap":182546284},{"date":"2020-12-18","current":-9.286097,"twenty":-0.920713,"median":-0.686941,"eighty":-0.229314,"marketCap":175237935},{"date":"2020-12-24","current":-8.214089,"twenty":-0.930237,"median":-0.687053,"eighty":-0.240945,"marketCap":155008068},{"date":"2020-12-31","current":-8.504134,"twenty":-0.934298,"median":-0.68952,"eighty":-0.246747,"marketCap":160481517},{"date":"2021-01-08","current":-8.680482,"twenty":-0.939914,"median":-0.692779,"eighty":-0.249588,"marketCap":163809374},{"date":"2021-01-15","current":-7.543504,"twenty":-0.949851,"median":-0.695822,"eighty":-0.253592,"marketCap":142353455},{"date":"2021-01-22","current":-7.784821,"twenty":-0.957365,"median":-0.69645,"eighty":-0.257462,"marketCap":146907364},{"date":"2021-01-29","current":-7.77322,"twenty":-0.965363,"median":-0.696821,"eighty":-0.26083,"marketCap":146688426},{"date":"2021-02-05","current":-8.186244,"twenty":-0.973225,"median":-0.697564,"eighty":-0.263229,"marketCap":154482617},{"date":"2021-02-12","current":-8.587667,"twenty":-0.98926,"median":-0.700307,"eighty":-0.266139,"marketCap":162057870},{"date":"2021-02-19","current":-8.374194,"twenty":-0.993238,"median":-0.70187,"eighty":-0.268444,"marketCap":158029412},{"date":"2021-02-26","current":-7.589911,"twenty":-1.001287,"median":-0.70338,"eighty":-0.269322,"marketCap":143229206},{"date":"2021-03-05","current":-7.536542,"twenty":-1.009777,"median":-0.704572,"eighty":-0.271644,"marketCap":142222092},{"date":"2021-03-12","current":-8.346349,"twenty":-1.013174,"median":-0.707049,"eighty":-0.274953,"marketCap":157503961},{"date":"2021-03-19","current":-7.875316,"twenty":-1.02385,"median":-0.708187,"eighty":-0.282521,"marketCap":148615080},{"date":"2021-03-26","current":-6.845074,"twenty":-1.029596,"median":-0.71031,"eighty":-0.285066,"marketCap":129173390},{"date":"2021-04-01","current":-7.096515,"twenty":-1.036961,"median":-0.710664,"eighty":-0.291055,"marketCap":125963136},{"date":"2021-04-09","current":-6.429728,"twenty":-1.044836,"median":-0.712614,"eighty":-0.291848,"marketCap":114127674},{"date":"2021-04-16","current":-6.347006,"twenty":-1.048794,"median":-0.713774,"eighty":-0.295853,"marketCap":112659365},{"date":"2021-04-23","current":-6.399647,"twenty":-1.052752,"median":-0.714717,"eighty":-0.299148,"marketCap":113593743},{"date":"2021-04-30","current":-6.69544,"twenty":-1.057219,"median":-0.717239,"eighty":-0.305441,"marketCap":118844061},{"date":"2021-05-07","current":-5.915851,"twenty":-1.06355,"median":-0.717239,"eighty":-0.30628,"marketCap":105006359},{"date":"2021-05-14","current":-3.654924,"twenty":-1.06988,"median":-0.71881,"eighty":-0.30704,"marketCap":101983342},{"date":"2021-05-21","current":-4.045612,"twenty":-1.077477,"median":-0.720566,"eighty":-0.308639,"marketCap":112884702},{"date":"2021-05-28","current":-4.16521,"twenty":-1.085074,"median":-0.720979,"eighty":-0.311038,"marketCap":116221854},{"date":"2021-06-04","current":-4.18594,"twenty":-1.089467,"median":-0.720979,"eighty":-0.315516,"marketCap":116800293},{"date":"2021-06-11","current":-4.119763,"twenty":-1.099941,"median":-0.722931,"eighty":-0.317754,"marketCap":114953736},{"date":"2021-06-18","current":-4.362946,"twenty":-1.110102,"median":-0.724861,"eighty":-0.31884,"marketCap":121739277},{"date":"2021-06-25","current":-3.973853,"twenty":-1.122632,"median":-0.725492,"eighty":-0.320315,"marketCap":110882412},{"date":"2021-07-02","current":-3.415727,"twenty":-1.134735,"median":-0.726043,"eighty":-0.329595,"marketCap":95309039},{"date":"2021-07-09","current":-3.511406,"twenty":-1.144489,"median":-0.727014,"eighty":-0.331857,"marketCap":97978760},{"date":"2021-07-16","current":-3.020256,"twenty":-1.160845,"median":-0.727634,"eighty":-0.333284,"marketCap":84274192},{"date":"2021-07-23","current":-3.288953,"twenty":-1.173703,"median":-0.728025,"eighty":-0.336476,"marketCap":91771659},{"date":"2021-07-30","current":-2.993147,"twenty":-1.188744,"median":-0.728605,"eighty":-0.340524,"marketCap":83517771},{"date":"2021-08-06","current":-3.004309,"twenty":-1.195229,"median":-0.728948,"eighty":-0.342222,"marketCap":83829239},{"date":"2021-08-13","current":-2.865729,"twenty":-1.19844,"median":-0.728948,"eighty":-0.342222,"marketCap":83197847},{"date":"2021-08-20","current":-2.889329,"twenty":-1.199291,"median":-0.728948,"eighty":-0.342222,"marketCap":83883005},{"date":"2021-08-27","current":-2.963501,"twenty":-1.209157,"median":-0.729291,"eighty":-0.342703,"marketCap":86036361},{"date":"2021-09-03","current":-3.059587,"twenty":-1.225828,"median":-0.729291,"eighty":-0.342703,"marketCap":88825936},{"date":"2021-09-10","current":-2.887643,"twenty":-1.246922,"median":-0.729291,"eighty":-0.342703,"marketCap":83834065},{"date":"2021-09-17","current":-2.909558,"twenty":-1.295574,"median":-0.729291,"eighty":-0.342703,"marketCap":84470284},{"date":"2021-09-24","current":-2.823586,"twenty":-1.309523,"median":-0.729291,"eighty":-0.342703,"marketCap":81974349},{"date":"2021-10-01","current":-2.639842,"twenty":-1.31973,"median":-0.729291,"eighty":-0.342703,"marketCap":76639899},{"date":"2021-10-08","current":-2.444298,"twenty":-1.342525,"median":-0.729291,"eighty":-0.342703,"marketCap":70962869},{"date":"2021-10-15","current":-2.526899,"twenty":-1.370424,"median":-0.729291,"eighty":-0.342703,"marketCap":73360925},{"date":"2021-10-22","current":-2.402155,"twenty":-1.429717,"median":-0.729291,"eighty":-0.342703,"marketCap":69739371},{"date":"2021-10-29","current":-2.569042,"twenty":-1.507874,"median":-0.729291,"eighty":-0.342703,"marketCap":74584422},{"date":"2021-11-05","current":-2.793243,"twenty":-2.429127,"median":-0.729291,"eighty":-0.342703,"marketCap":81093430},{"date":"2021-11-12","current":-1.949966,"twenty":-2.43823,"median":-0.729291,"eighty":-0.342703,"marketCap":57013115},{"date":"2021-11-19","current":-1.222917,"twenty":-2.43823,"median":-0.729291,"eighty":-0.342703,"marketCap":35755648},{"date":"2021-11-26","current":-2.189524,"twenty":-2.441939,"median":-0.729291,"eighty":-0.342703,"marketCap":64017304},{"date":"2021-12-03","current":-1.177686,"twenty":-2.441939,"median":-0.729291,"eighty":-0.342703,"marketCap":34433179},{"date":"2021-12-10","current":-1.301653,"twenty":-2.441939,"median":-0.729291,"eighty":-0.342703,"marketCap":38057724},{"date":"2021-12-17","current":-1.360286,"twenty":-2.441939,"median":-0.729433,"eighty":-0.342703,"marketCap":39772036},{"date":"2021-12-23","current":-1.318405,"twenty":-2.441939,"median":-0.729433,"eighty":-0.342703,"marketCap":38547527},{"date":"2021-12-31","current":-1.318405,"twenty":-2.441939,"median":-0.729433,"eighty":-0.342703,"marketCap":38547527},{"date":"2022-01-07","current":-1.237994,"twenty":-2.441264,"median":-0.729433,"eighty":-0.343184,"marketCap":36196471},{"date":"2022-01-14","current":-1.209565,"twenty":-2.441264,"median":-0.729433,"eighty":-0.343184,"marketCap":35365274},{"date":"2022-01-21","current":-0.98671,"twenty":-2.441264,"median":-0.729433,"eighty":-0.343184,"marketCap":28849420},{"date":"2022-01-28","current":-0.909649,"twenty":-2.44059,"median":-0.729433,"eighty":-0.343666,"marketCap":26596324},{"date":"2022-02-04","current":-0.934778,"twenty":-2.44059,"median":-0.729433,"eighty":-0.343666,"marketCap":27331029},{"date":"2022-02-11","current":-0.985035,"twenty":-2.439915,"median":-0.729433,"eighty":-0.344147,"marketCap":28800439},{"date":"2022-02-18","current":-0.967608,"twenty":-2.439915,"median":-0.729433,"eighty":-0.344147,"marketCap":28290911},{"date":"2022-02-25","current":-0.974458,"twenty":-2.439915,"median":-0.729433,"eighty":-0.344147,"marketCap":28491201},{"date":"2022-03-04","current":-0.907667,"twenty":-2.439915,"median":-0.729433,"eighty":-0.344147,"marketCap":26538377},{"date":"2022-03-11","current":-0.813475,"twenty":-2.439915,"median":-0.730884,"eighty":-0.344147,"marketCap":23784394},{"date":"2022-03-18","current":-0.869991,"twenty":-2.439915,"median":-0.731099,"eighty":-0.344147,"marketCap":25436784},{"date":"2022-03-25","current":-1.068066,"twenty":-2.439915,"median":-0.731664,"eighty":-0.344147,"marketCap":30393952},{"date":"2022-04-01","current":-1.108536,"twenty":-2.439915,"median":-0.732068,"eighty":-0.344147,"marketCap":31545618},{"date":"2022-04-08","current":-0.948414,"twenty":-2.439915,"median":-0.733014,"eighty":-0.344147,"marketCap":26989028},{"date":"2022-04-14","current":-0.837561,"twenty":-2.439915,"median":-0.735904,"eighty":-0.344147,"marketCap":23834467},{"date":"2022-04-22","current":-0.823484,"twenty":-2.439915,"median":-0.738671,"eighty":-0.344147,"marketCap":23433887},{"date":"2022-04-29","current":-0.749582,"twenty":-2.439915,"median":-0.739917,"eighty":-0.344147,"marketCap":21330846},{"date":"2022-05-06","current":-0.710871,"twenty":-2.439915,"median":-0.740753,"eighty":-0.344147,"marketCap":20229253},{"date":"2022-05-13","current":-0.797056,"twenty":-2.439915,"median":-0.741669,"eighty":-0.344147,"marketCap":23033313},{"date":"2022-05-20","current":-0.788392,"twenty":-2.439915,"median":-0.744513,"eighty":-0.344147,"marketCap":22782951},{"date":"2022-05-27","current":-0.845572,"twenty":-2.439915,"median":-0.74549,"eighty":-0.344147,"marketCap":24435340},{"date":"2022-06-03","current":-0.864632,"twenty":-2.439915,"median":-0.745907,"eighty":-0.344147,"marketCap":24986137},{"date":"2022-06-10","current":-0.689626,"twenty":-2.439915,"median":-0.748131,"eighty":-0.344147,"marketCap":19928823},{"date":"2022-06-17","current":-0.60299,"twenty":-2.439915,"median":-0.747837,"eighty":-0.344147,"marketCap":17425202},{"date":"2022-06-24","current":-0.672299,"twenty":-2.44059,"median":-0.745751,"eighty":-0.343666,"marketCap":19428098},{"date":"2022-07-01","current":-0.620317,"twenty":-2.44059,"median":-0.745306,"eighty":-0.343666,"marketCap":17925926},{"date":"2022-07-08","current":-0.722548,"twenty":-2.44059,"median":-0.745306,"eighty":-0.343666,"marketCap":20880199},{"date":"2022-07-15","current":-0.67923,"twenty":-2.44059,"median":-0.745306,"eighty":-0.343666,"marketCap":19628388},{"date":"2022-07-22","current":-0.696557,"twenty":-2.44059,"median":-0.745673,"eighty":-0.343666,"marketCap":20129112},{"date":"2022-07-29","current":-0.682695,"twenty":-2.44059,"median":-0.745673,"eighty":-0.343666,"marketCap":19728533},{"date":"2022-08-05","current":-0.743341,"twenty":-2.44059,"median":-0.745673,"eighty":-0.343666,"marketCap":21481068},{"date":"2022-08-12","current":3.1943,"twenty":-2.44059,"median":-0.746063,"eighty":-0.336476,"marketCap":22500646},{"date":"2022-08-19","current":2.478834,"twenty":-2.44059,"median":-0.746063,"eighty":-0.318638,"marketCap":17460908},{"date":"2022-08-26","current":2.616146,"twenty":-2.44059,"median":-0.746063,"eighty":-0.306736,"marketCap":18428131},{"date":"2022-09-02","current":2.579939,"twenty":-2.44059,"median":-0.746063,"eighty":-0.291531,"marketCap":18173090},{"date":"2022-09-09","current":2.764298,"twenty":-2.44059,"median":-0.745751,"eighty":-0.272385,"marketCap":19471713},{"date":"2022-09-16","current":2.587238,"twenty":-2.44059,"median":-0.745751,"eighty":-0.261309,"marketCap":18224505},{"date":"2022-09-23","current":2.2548,"twenty":-2.44059,"median":-0.745751,"eighty":-0.238037,"marketCap":15882809},{"date":"2022-09-30","current":2.196984,"twenty":-2.44059,"median":-0.744541,"eighty":2.2548,"marketCap":15475557},{"date":"2022-10-07","current":2.124715,"twenty":-2.44059,"median":-0.743341,"eighty":2.260582,"marketCap":14966493},{"date":"2022-10-14","current":2.045219,"twenty":-2.44059,"median":-0.739917,"eighty":2.260582,"marketCap":14406522},{"date":"2022-10-21","current":2.059673,"twenty":-2.44059,"median":-0.737228,"eighty":2.260582,"marketCap":14508335},{"date":"2022-10-28","current":2.16085,"twenty":-2.44059,"median":-0.733054,"eighty":2.260582,"marketCap":15221025},{"date":"2022-11-04","current":2.074127,"twenty":-2.44059,"median":-0.730668,"eighty":2.260582,"marketCap":14610148},{"date":"2022-11-11","current":2.507275,"twenty":-2.44059,"median":-0.728605,"eighty":2.298162,"marketCap":16039037},{"date":"2022-11-18","current":2.483396,"twenty":-2.44059,"median":-0.728605,"eighty":2.476795,"marketCap":15886284},{"date":"2022-11-25","current":2.316244,"twenty":-2.44059,"median":-0.728605,"eighty":2.476795,"marketCap":14817015},{"date":"2022-12-02","current":2.467556,"twenty":-2.44059,"median":-0.728605,"eighty":2.478834,"marketCap":15784958},{"date":"2022-12-09","current":2.764529,"twenty":-2.44059,"median":-0.728025,"eighty":2.519025,"marketCap":17684693},{"date":"2022-12-16","current":1.719274,"twenty":-2.44059,"median":-0.727014,"eighty":2.542431,"marketCap":10998197},{"date":"2022-12-23","current":1.647638,"twenty":-2.44059,"median":-0.722548,"eighty":2.542431,"marketCap":10539939},{"date":"2022-12-30","current":1.846628,"twenty":-2.44059,"median":-0.719816,"eighty":2.542431,"marketCap":11812878},{"date":"2023-01-06","current":1.735193,"twenty":-2.44059,"median":-0.719816,"eighty":2.483396,"marketCap":11100032},{"date":"2023-01-13","current":1.790911,"twenty":-2.44059,"median":-0.719816,"eighty":2.467509,"marketCap":11456455},{"date":"2023-01-20","current":1.910305,"twenty":-2.44059,"median":-0.719816,"eighty":2.407217,"marketCap":12220219},{"date":"2023-01-27","current":1.902345,"twenty":-2.44059,"median":-0.719816,"eighty":2.306693,"marketCap":12169301},{"date":"2023-02-03","current":1.703355,"twenty":-2.44059,"median":-0.719816,"eighty":2.257091,"marketCap":10896362},{"date":"2023-02-10","current":1.679476,"twenty":-2.44059,"median":-0.719816,"eighty":2.192648,"marketCap":10743609},{"date":"2023-02-17","current":1.587383,"twenty":-2.44059,"median":-0.719816,"eighty":2.166632,"marketCap":10154492},{"date":"2023-02-24","current":1.59988,"twenty":-2.44059,"median":-0.719816,"eighty":2.134833,"marketCap":10234433},{"date":"2023-03-03","current":1.711315,"twenty":-2.44059,"median":-0.719816,"eighty":2.103034,"marketCap":10947279},{"date":"2023-03-10","current":1.480486,"twenty":-2.44059,"median":-0.719816,"eighty":2.062564,"marketCap":9470669},{"date":"2023-03-17","current":1.40885,"twenty":-2.44059,"median":-0.719816,"eighty":2.025349,"marketCap":9012411},{"date":"2023-03-24","current":1.472526,"twenty":-2.44059,"median":-0.719816,"eighty":1.93461,"marketCap":9419752},{"date":"2023-03-31","current":1.639331,"twenty":-2.439915,"median":-0.71945,"eighty":1.902345,"marketCap":13158908},{"date":"2023-04-06","current":1.474189,"twenty":-2.439915,"median":-0.71945,"eighty":1.846628,"marketCap":11833318},{"date":"2023-04-14","current":1.704572,"twenty":-2.44059,"median":-0.719816,"eighty":1.817973,"marketCap":13682600},{"date":"2023-04-21","current":1.650459,"twenty":-2.44059,"median":-0.719816,"eighty":1.790911,"marketCap":13248231},{"date":"2023-04-28","current":1.777625,"twenty":-2.44059,"median":-0.719816,"eighty":1.741561,"marketCap":14268997},{"date":"2023-05-05","current":1.56027,"twenty":-2.44059,"median":-0.719816,"eighty":1.719274,"marketCap":12524284},{"date":"2023-05-12","current":1.524194,"twenty":-2.44059,"median":-0.719816,"eighty":1.711315,"marketCap":12234705},{"date":"2023-05-19","current":0.661443,"twenty":-2.44059,"median":-0.719816,"eighty":1.695553,"marketCap":12234705},{"date":"2023-05-26","current":0.642423,"twenty":-2.44059,"median":-0.719816,"eighty":1.682299,"marketCap":11882897},{"date":"2023-06-02","current":0.618775,"twenty":-2.44059,"median":-0.719816,"eighty":1.671516,"marketCap":11445489},{"date":"2023-06-09","current":0.63454,"twenty":-2.44059,"median":-0.719816,"eighty":1.655597,"marketCap":11737094},{"date":"2023-06-16","current":0.630599,"twenty":-2.44059,"median":-0.719816,"eighty":1.642208,"marketCap":11664193},{"date":"2023-06-23","current":0.563598,"twenty":-2.441264,"median":-0.720122,"eighty":1.63214,"marketCap":10424873},{"date":"2023-06-30","current":0.571481,"twenty":-2.441939,"median":-0.720428,"eighty":1.615799,"marketCap":10570675},{"date":"2023-07-07","current":0.591379,"twenty":-2.441939,"median":-0.720428,"eighty":1.599173,"marketCap":10938742},{"date":"2023-07-14","current":0.636199,"twenty":-2.441939,"median":-0.720428,"eighty":1.586653,"marketCap":11767766},{"date":"2023-07-21","current":0.428256,"twenty":-2.441939,"median":-0.720428,"eighty":1.558393,"marketCap":7921442},{"date":"2023-07-28","current":0.424177,"twenty":-2.441939,"median":-0.720428,"eighty":1.502919,"marketCap":7846000},{"date":"2023-08-04","current":0.244717,"twenty":-2.441939,"median":-0.720428,"eighty":1.479227,"marketCap":4526538},{"date":"2023-08-11","current":-0.252576,"twenty":-2.441939,"median":-0.720428,"eighty":1.43432,"marketCap":4410226},{"date":"2023-08-18","current":-0.276461,"twenty":-2.441939,"median":-0.720428,"eighty":0.723408,"marketCap":4827284},{"date":"2023-08-25","current":-0.254418,"twenty":-2.441939,"median":-0.720428,"eighty":0.661992,"marketCap":4442392},{"date":"2023-09-01","current":-0.290386,"twenty":-2.441939,"median":-0.720428,"eighty":0.646249,"marketCap":5070435},{"date":"2023-09-08","current":-0.263988,"twenty":-2.441939,"median":-0.720428,"eighty":0.635867,"marketCap":4609486},{"date":"2023-09-15","current":-0.257586,"twenty":-2.441939,"median":-0.720428,"eighty":0.630506,"marketCap":4497706},{"date":"2023-09-22","current":-0.22109,"twenty":-2.441939,"median":-0.720428,"eighty":0.622717,"marketCap":3860444},{"date":"2023-09-29","current":-0.20822,"twenty":-2.441939,"median":-0.720428,"eighty":0.609249,"marketCap":3635732},{"date":"2023-10-06","current":-0.20921,"twenty":-2.441939,"median":-0.720428,"eighty":0.582476,"marketCap":3653017},{"date":"2023-10-13","current":-0.250788,"twenty":-2.441939,"median":-0.720428,"eighty":0.560099,"marketCap":4379012},{"date":"2023-10-20","current":-0.227029,"twenty":-2.441939,"median":-0.720428,"eighty":0.442123,"marketCap":3964158},{"date":"2023-10-27","current":-0.213299,"twenty":-2.443287,"median":-0.721556,"eighty":0.424177,"marketCap":3724407},{"date":"2023-11-03","current":-0.177598,"twenty":-2.443287,"median":-0.721556,"eighty":0.331961,"marketCap":3101031},{"date":"2023-11-10","current":-0.153773,"twenty":-2.443287,"median":-0.721556,"eighty":0.245484,"marketCap":2685025},{"date":"2023-11-17","current":-0.129865,"twenty":-2.443287,"median":-0.71945,"eighty":-0.117527,"marketCap":2097316},{"date":"2023-11-24","current":-0.209929,"twenty":-2.443287,"median":-0.713851,"eighty":-0.117527,"marketCap":3390347},{"date":"2023-12-01","current":-0.203984,"twenty":-2.443287,"median":-0.709909,"eighty":-0.117527,"marketCap":3294336},{"date":"2023-12-08","current":-0.210201,"twenty":-2.44295,"median":-0.705221,"eighty":-0.117764,"marketCap":3394751},{"date":"2023-12-15","current":-0.191985,"twenty":-2.44295,"median":-0.698297,"eighty":-0.117764,"marketCap":3100551},{"date":"2023-12-22","current":-0.201802,"twenty":-2.44295,"median":-0.696557,"eighty":-0.117764,"marketCap":3259102},{"date":"2023-12-29","current":-0.206602,"twenty":-2.443287,"median":-0.696557,"eighty":-0.117527,"marketCap":3336616},{"date":"2024-01-05","current":-0.206134,"twenty":-2.443624,"median":-0.696557,"eighty":-0.117289,"marketCap":3329059},{"date":"2024-01-12","current":-0.185952,"twenty":-2.443624,"median":-0.693423,"eighty":-0.117289,"marketCap":3003124},{"date":"2024-01-19","current":-0.211307,"twenty":-2.443961,"median":-0.688725,"eighty":-0.117052,"marketCap":3412604},{"date":"2024-01-26","current":-0.214349,"twenty":-2.443624,"median":-0.687824,"eighty":-0.117289,"marketCap":3461738},{"date":"2024-02-02","current":-0.211583,"twenty":-2.443624,"median":-0.686966,"eighty":-0.117289,"marketCap":3417070},{"date":"2024-02-09","current":-0.203286,"twenty":-2.443624,"median":-0.683062,"eighty":-0.117289,"marketCap":3283068},{"date":"2024-02-16","current":-0.217115,"twenty":-2.443624,"median":-0.67923,"eighty":-0.117289,"marketCap":3506405},{"date":"2024-02-23","current":-0.192223,"twenty":-2.443624,"median":-0.678183,"eighty":-0.117289,"marketCap":3104397},{"date":"2024-03-01","current":-0.235093,"twenty":-2.443287,"median":-0.675863,"eighty":-0.117527,"marketCap":3796745},{"date":"2024-03-08","current":-0.202221,"twenty":-2.443287,"median":-0.67223,"eighty":-0.117527,"marketCap":3520869},{"date":"2024-03-15","current":-0.154423,"twenty":-2.443287,"median":-0.667339,"eighty":-0.117527,"marketCap":2688663},{"date":"2024-03-22","current":-0.137265,"twenty":-2.443287,"median":-0.664222,"eighty":-0.117527,"marketCap":2389923},{"date":"2024-03-28","current":-0.124396,"twenty":-2.443287,"median":-0.663546,"eighty":-0.117527,"marketCap":2165867},{"date":"2024-04-05","current":-0.1054,"twenty":-2.443624,"median":-0.659831,"eighty":-0.109812,"marketCap":1835119},{"date":"2024-04-12","current":-0.029353,"twenty":-2.443624,"median":-0.653239,"eighty":-0.047026,"marketCap":511059},{"date":"2024-04-19","current":-0.064574,"twenty":-2.443624,"median":-0.647364,"eighty":-0.041513,"marketCap":1124300},{"date":"2024-04-26","current":-0.062756,"twenty":-2.443287,"median":-0.646527,"eighty":-0.047466,"marketCap":1092647},{"date":"2024-05-03","current":-0.104286,"twenty":-2.443287,"median":-0.646527,"eighty":-0.047466,"marketCap":1815723},{"date":"2024-05-10","current":-0.055607,"twenty":-2.443287,"median":-0.644437,"eighty":-0.045105,"marketCap":1502390},{"date":"2024-05-17","current":-0.047352,"twenty":-2.443287,"median":-0.641613,"eighty":-0.040152,"marketCap":1279362},{"date":"2024-05-24","current":-0.043409,"twenty":-2.443287,"median":-0.639004,"eighty":-0.037787,"marketCap":1172828},{"date":"2024-05-31","current":-0.043147,"twenty":-2.443287,"median":-0.639004,"eighty":-0.037112,"marketCap":1165758},{"date":"2024-06-07","current":-0.128062,"twenty":-2.443287,"median":-0.635199,"eighty":-0.037112,"marketCap":3459983},{"date":"2024-06-14","current":-0.117944,"twenty":-2.443624,"median":-0.628515,"eighty":-0.034526,"marketCap":3186611},{"date":"2024-06-21","current":-0.081549,"twenty":-2.443961,"median":-0.62588,"eighty":-0.031939,"marketCap":2203291},{"date":"2024-06-28","current":-0.077758,"twenty":-2.445647,"median":-0.620611,"eighty":0.080275,"marketCap":2100879},{"date":"2024-07-05","current":-0.089228,"twenty":-2.445647,"median":-0.617391,"eighty":0.080275,"marketCap":2410765},{"date":"2024-07-12","current":-0.094359,"twenty":-2.445647,"median":-0.614756,"eighty":0.080275,"marketCap":2549403},{"date":"2024-07-15","current":-0.151041,"twenty":-2.445647,"median":-0.61378,"eighty":0.080275,"marketCap":4080820},{"date":"2024-08-02","current":-0.193713,"twenty":-2.457784,"median":-0.604315,"eighty":0.260287,"marketCap":5233726},{"date":"2024-08-09","current":-0.218472,"twenty":-2.457784,"median":-0.601492,"eighty":0.260287,"marketCap":5451527},{"date":"2024-08-16","current":-0.164225,"twenty":-2.457784,"median":-0.596512,"eighty":0.260287,"marketCap":4097912},{"date":"2024-08-23","current":-0.143688,"twenty":-2.457784,"median":-0.5893,"eighty":0.260287,"marketCap":3585438},{"date":"2024-08-30","current":-0.13357,"twenty":-2.457784,"median":-0.583361,"eighty":0.260287,"marketCap":3332969},{"date":"2024-09-06","current":-0.127907,"twenty":-2.457784,"median":-0.577032,"eighty":0.260287,"marketCap":3191661},{"date":"2024-09-13","current":-0.136062,"twenty":-2.457784,"median":-0.576354,"eighty":0.260287,"marketCap":3395144},{"date":"2024-09-20","current":-0.06645,"twenty":-2.457784,"median":-0.572055,"eighty":0.260287,"marketCap":1658126},{"date":"2024-09-27","current":-0.096959,"twenty":-2.457784,"median":-0.570105,"eighty":0.260287,"marketCap":2419411},{"date":"2024-10-04","current":-0.091033,"twenty":-2.457784,"median":-0.570105,"eighty":0.260287,"marketCap":2271558},{"date":"2024-10-11","current":-0.080691,"twenty":-2.457784,"median":-0.570105,"eighty":0.260287,"marketCap":2013487},{"date":"2024-10-18","current":-0.086509,"twenty":-2.457784,"median":-0.570105,"eighty":0.260287,"marketCap":2158652},{"date":"2024-10-25","current":-0.132995,"twenty":-2.457784,"median":-0.564259,"eighty":0.260287,"marketCap":3318625},{"date":"2024-10-31","current":-0.150717,"twenty":-2.457784,"median":-0.564259,"eighty":0.260287,"marketCap":3760840},{"date":"2024-11-08","current":-0.175098,"twenty":-2.458458,"median":-0.556208,"eighty":0.261026,"marketCap":4153322},{"date":"2024-11-15","current":-0.188079,"twenty":-2.458458,"median":-0.539719,"eighty":0.261026,"marketCap":4461412},{"date":"2024-11-22","current":-0.208213,"twenty":-2.458458,"median":-0.506442,"eighty":0.261026,"marketCap":4939024},{"date":"2024-11-29","current":-0.218593,"twenty":-2.458458,"median":-0.489951,"eighty":0.261026,"marketCap":5185234},{"date":"2024-12-06","current":-0.210499,"twenty":-2.458458,"median":-0.476778,"eighty":0.261026,"marketCap":4993253},{"date":"2024-12-13","current":-0.118749,"twenty":-2.458458,"median":-0.434525,"eighty":0.261026,"marketCap":2816835},{"date":"2024-12-20","current":-0.095547,"twenty":-2.458458,"median":-0.409837,"eighty":0.261026,"marketCap":2266476},{"date":"2024-12-27","current":-0.107781,"twenty":-2.458458,"median":-0.399792,"eighty":0.261026,"marketCap":2556665},{"date":"2025-01-03","current":-0.096391,"twenty":-2.458458,"median":-0.390321,"eighty":0.261026,"marketCap":2286489},{"date":"2025-01-10","current":-0.105039,"twenty":-2.459133,"median":-0.357144,"eighty":0.261765,"marketCap":2491623},{"date":"2025-01-17","current":-0.095125,"twenty":-2.459133,"median":-0.333049,"eighty":0.261765,"marketCap":2256470},{"date":"2025-01-24","current":-0.097235,"twenty":-2.459133,"median":-0.318538,"eighty":0.261765,"marketCap":2306502},{"date":"2025-01-31","current":-0.094071,"twenty":-2.459133,"median":-0.30666,"eighty":0.261765,"marketCap":2231453},{"date":"2025-02-07","current":-0.090907,"twenty":-2.459133,"median":-0.293851,"eighty":0.261765,"marketCap":2156405},{"date":"2025-02-14","current":-0.076775,"twenty":-2.459133,"median":-0.282033,"eighty":0.261765,"marketCap":1821186},{"date":"2025-02-21","current":-0.206104,"twenty":-2.459133,"median":-0.27524,"eighty":0.261765,"marketCap":4973297},{"date":"2025-02-28","current":-0.216984,"twenty":-2.459133,"median":-0.270257,"eighty":0.261765,"marketCap":5235817},{"date":"2025-03-07","current":-0.161982,"twenty":-2.459807,"median":-0.264668,"eighty":0.262505,"marketCap":3908632},{"date":"2025-03-14","current":-0.14385,"twenty":-2.459807,"median":-0.262269,"eighty":0.262505,"marketCap":3471099},{"date":"2025-03-21","current":-0.149284,"twenty":-2.459807,"median":-0.26082,"eighty":0.262505,"marketCap":3602213},{"date":"2025-03-28","current":-0.075551,"twenty":-2.459807,"median":-0.257454,"eighty":0.262505,"marketCap":1823056},{"date":"2025-04-01","current":-0.070112,"twenty":-2.459807,"median":-0.255408,"eighty":0.262505,"marketCap":1691796}],"updateTime":1743634558225}}}